Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism

This publication has 25 references indexed in Scilit:

• Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
  New England Journal of Medicine, 1997
• Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
  The Lancet, 1996
• Risk of venous thromboembolism in users of hormone replacement therapy
  The Lancet, 1996
• Prospective study of exogenous hormones and risk of pulmonary embolism in women
  The Lancet, 1996
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995
• The natural history and epidemiology of venous thrombosis
  Progress in Cardiovascular Diseases, 1994
• Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.
  BMJ, 1992
• A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
  Journal of Internal Medicine, 1992
• Hemostatic factors according to menopausal status and use of hormone replacement therapy
  Annals of Epidemiology, 1992
• Oral contraceptives and venous thromboembolism: findings in a large prospective study.
  BMJ, 1986